FRI0254 Predictive Value of Pretreatment Resistin Levels for Erosive Disease in Early RA Treated with DMARDS and Infliximab

K. Vuolteenaho; H. Kautiainen; T. Möttönen; P. Hannonen; M. Korpela; M. Kauppi; O. Kaipiainen-Seppänen; R. Luosujärvi; R. Nieminen; M. Leirisalo-Repo; E. Moilanen

doi:10.1136/annrheumdis-2014-eular.1680

Article info

EULAR 2014: Scientific Abstracts

Poster Presentations. Rheumatoid arthritis - anti-TNF therapy

FRI0254 Predictive Value of Pretreatment Resistin Levels for Erosive Disease in Early RA Treated with DMARDS and Infliximab

Authors

K. Vuolteenaho 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere PubMed articles Google scholar articles
H. Kautiainen 2Medcare Ltd, Äänekoski PubMed articles Google scholar articles
T. Möttönen 3Turku University Hospital, Turku PubMed articles Google scholar articles
P. Hannonen 4Jyväskylä Central Hospital, Jyväskylä PubMed articles Google scholar articles
M. Korpela 5Tampere University Hospital, Tampere PubMed articles Google scholar articles
M. Kauppi 6Päijät-Häme Central Hospital, Lahti PubMed articles Google scholar articles
O. Kaipiainen-Seppänen 7Kuopio University Hospital, Kuopio PubMed articles Google scholar articles
R. Luosujärvi 8Helsinki University Central Hospital, Helsinki, Finland PubMed articles Google scholar articles
R. Nieminen 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere PubMed articles Google scholar articles
M. Leirisalo-Repo 8Helsinki University Central Hospital, Helsinki, Finland PubMed articles Google scholar articles
E. Moilanen 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere PubMed articles Google scholar articles

Citation

Vuolteenaho K, Kautiainen H, Möttönen T, et al

FRI0254 Predictive Value of Pretreatment Resistin Levels for Erosive Disease in Early RA Treated with DMARDS and Infliximab

Annals of the Rheumatic Diseases 2014;73:475.

Publication history

First published June 10, 2014.

Online issue publication

April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password